Dr. Espy Schaefer is a hepatologist and GI/liver hospitalist at Mass General Brigham, where she has served on the faculty since completing her residency and GI fellowship at MGH. She holds an undergraduate degree from Yale and an MD/MPH from Columbia University. After starting her research career as a basic and translational investigator in viral hepatitis, she co-founded the MGB alcohol liver disease clinic and biorepository which forms the basis of much of her current clinical research, including integrated addiction and hepatology care and biomarkers in ALD. Dr.

I am a transplant hepatologist at Thomas Jeffersno University. I have a special interest in alcohol associated liver disease and alcohol use disorder.

Dr. Sonali Paul is Associate Professor of Medicine and Section Chief of Gastroenterology, Hepatology, and Nutrition at the University of Chicago. A transplant hepatologist, her clinical and research interests focus on metabolic dysfunction–associated steatotic liver disease (MASLD), obesity medicine, and liver transplantation.

Dr. Rebecca Roediger's clinical and research interest focuses on advancing innovative models of integrated care for patients with alcohol related liver disease and alcohol use disorder. She is a transplant hepatologist at Weill Cornell Medicine and Medical Director of the Center for Alcohol and Liver Medicine, an integrated addiction and hepatology program dedicated to the treatment of alcohol-associated liver disease. She previously established and served as Medical Director of METRIC, Montefiore Einstein's multidisciplinary alcohol-related liver disease clinic. Dr.

Dr. Brittany Bromfield earned her medical degree from the University of the West Indies in Jamaica and completed her internal medicine residency at the University of Pittsburgh Medical Center. She completed her gastroenterology fellowship at Brigham and Women's Hospital, where she is currently pursuing advanced research training in hepatology. She also holds a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health.

I am an Associate Professor of Medicine in the Karsh Division of Gastroenterology and Hepatology and serve as Medical Director of the Liver Cancer Program at Cedars-Sinai Cancer. My research focuses on clinical and translational studies in liver cancer, with particular expertise in liver cirrhosis epidemiology, risk stratification, surveillance, early cancer detection, diagnosis, and treatment.

Wendy Spearman: MBChB, MMed, PhD, FCP(SA), FRCP (London)

Wendy Spearman is Emeritus Professor of Medicine and a Consultant Hepatologist in the Division of Hepatology, Department of Medicine, Faculty of Health Sciences at the University of Cape Town. She was appointed as a University of Cape Town Senior Research Scholar in July 2024.
She was Head of the Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Head of Liver Transplantation, Groote Schuur Hospital, Cape Town, South Africa from 1/01/1998 - 30/06/2024.

Jennifer Onwochei, MD, is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwell Health. Her clinical and academic interests include liver transplantation, community health, global outreach, and medical education. Dr. Onwochei is committed to advancing equitable liver care through patient-centered practice, mentorship, and community engagement.

Mohamed El-Kassas, MD, is Professor and Head of Endemic Medicine and HepatoGastroenterology at the Faculty of Medicine, Capital University, Cairo, Egypt. He is President of the Steatotic Liver Diseases Study Foundation in Middle East and North Africa and serves on several international liver disease committees, including IASL, WGO, AHPBCC, and the Global NASH Council.

Dr. Vos is a Professor of Pediatrics and Associate Chair of Translational Research in the Department of Pediatrics at Michigan State University, as well as the Director of Research for Helen DeVos Children's Hospital at Corewell Health. She has investigated MASLD in children for more than 20 years, contributing to improved dietary strategies and advancing the understanding of emerging therapies and biomarkers. She has authored over 150 peer‑reviewed publications on MASLD and related topics and has maintained continuous NIH funding since 2007. Dr.